Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2026-01-06 @ 7:36 PM
Study NCT ID:
NCT04074993
Status:
UNKNOWN
Last Update Posted:
2023-09-28
First Post:
2019-08-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Brigatinib in ALK-positive NSCLC Identified Via Blood-based Assays
Sponsor:
JI-YOUN HAN
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
NCC2019-0212
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None